Clinical implications of body mass index in metastatic breast cancer patients treated with abemaciclib and endocrine therapy.
Authors : Franzoi MA, Eiger D, Ameye L, Ponde N, Caparica R, de Angelis C, Brandão M, Desmedt C, Di Cosimo S, Kotecki N, Lambertini M, Awada A, Piccart M, de Azambuja E Year : 2020 Journal : J Natl Cancer Inst
Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitors.
Authors : Franzoi MA, Vandeputte C, Eiger D, Caparica R, Brandão M, de Angelis C, Hendlisz A, Awada A, Piccart M, de Azambuja E Year : 2020 Journal : Breast Cancer Res Treat
Prognostic and Predictive Impact of Beta-2 Adrenergic Receptor Expression in HER2-Positive Breast Cancer.
Authors : Caparica R, Richard F, Brandão M, Awada A, Sotiriou C, de Azambuja E Year : 2020 Journal : Clin Breast Cancer
Lessons learned at SABCS 2019 and to-dos from immunotherapy in breast cancer.
Authors : Eiger D, Brandão M, de Azambuja E Year : 2020 Journal : ESMO Open
Cardiotoxicity of trastuzumab given for 12 months compared to shorter treatment periods: a systematic review and meta-analysis of six clinical trials.
Authors : Eiger D, Franzoi MA, Pondé N, Brandão M, de Angelis C, Schmitt Nogueira M, de Hemptinne Q, de Azambuja E Year : 2020 Journal : ESMO Open